Found 36 matching trials
Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma
N/AEpstein-Barr virus (EBV) has been proven to process a strong association in...
Location
Taichung Veteran General Hospital
Verification of Harmonization of Plasma Epstein-Barr Virus DNA Measurements
N/APlasma Epstein-Barr virus (EBV) DNA will be measured in native plasma sampl...
Location
Sun Yat-sen University Cancer Center
Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy
N/AHow does plasma Epstein-Barr Virus (EBV) DNA level change during definitive...
Location
Multiple Locations
The Value of Post-radiation Detectable Plasma EBV DNA in High-risk Nasopharyngeal Carcinoma Patients
N/AAn additional blood test at 2-3 months after RT is a valuable biomarker in ...
Location
Multiple Locations
Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma
PHASE2This is the first phase II randomized clinical trial of concurrent chemorad...
Status
Active Not Recruiting
Location
Sun Yat-sen Universitty Cancer Center
Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma
PHASE3This is a phase III randomized clinical trial of definitive radiotherapy pl...
Status
Active Not Recruiting
Location
Sun Yat-sen Universitty Cancer Center
Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases
N/AThis is a multicenter, non-interventional, ambidirectional cohort study of ...
Location
Fudan University Shanghai Cancer Center
New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer
N/AThe combination of pEBV DNA (half-life) and PET-CT following 1 course of ch...
Location
Department of Clinical Oncology, Prince of Wales Hospital
Screening for Early Diagnosis of Nose Cancer
NAThe goal of this clinical trial is to evaluate the effectiveness of screeni...
Location
National University Hospital
Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA
N/ANo previous study reported the treatment outcome of stage III nasopharyngea...
Location
Multiple Locations